The Recall Desk
Agency classClass IIOur severity:HighFDA (Devices)·Z-0837-2021·Announced 2021-01-20

Fresenius Naturalyte Liquid Acid concentrate bottles recalled for conductivity deviation

Fresenius Medical Care is recalling Naturalyte Liquid Acid concentrate bottles due to deviations in conductivity and calcium concentration.

The agency’s classification

FDA (Devices): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 3/5 (High).

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: The recall involves a medical device used in hemodialysis with deviations in chemical specifications (sodium conductivity and calcium concentration) that could affect patient safety, but no specific injuries or illnesses are reported in the source text, fitting the 'High' severity criteria for risk-of-harm products where injury has not yet been reported.

Plain-English summary

Fresenius Medical Care Holdings, Inc. is recalling Naturalyte Liquid Acid concentrate bottles, Product Code 08-3251-9. The product is used in conjunction with Fresenius Renal Technologies Sodium Bicarbonate Concentrate in a compatible 45X dilution three-stream artificial kidney (hemodialysis) machine. The recall involves 5,079 cases distributed nationwide in the United States.

The recall was initiated because the deviation in conductivity for sodium level exceeds 0.6mS/cm from the theoretical conductivity (TCD) or approximately 6mEq/L of sodium from prescriptions that was previously communicated. Additionally, the calcium concentration is below manufacturing specification.

Affected lot numbers include 20LXAC058, 20LXAC078, 20LXAC096, 20NXAC011, 20NXAC012, 20LXAC060, 20NXAC026, 20LXAC045, 20LXAC043, 20LXAC059, 20LXAC044, and 20LXAC079. Consumers and healthcare facilities should stop using the affected product and contact the manufacturer for further instructions.

The recalled product

Product
Naturalyte Liquid Acid concentrate bottles, Product Code 08-3251-9 - Product Usage: used in conjunction with Fresenius Renal Technologies Sodium Bicarbonate Concentrate in a compatible 45X dilution three-stream artificial kidney (hemodialysis) machine.
Affected units
5,079

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 11 recalled by Fresenius Medical Care Holdings, Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 11 products in this recall →

Same manufacturer · Fresenius Medical Care Holdings, Inc.

See all →

Similar recalls